메디톡스, ICLAS 서울 2026서 톡신·필러 포트폴리오 임상 지견 공유
Predicted impact: Low
Quarterly cash dividend of KRW 1,200 per share, already announced in the last 14 days.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.